- 
							【GE CHENG News】China’s first research report on automotive standard-essential patents releases, addressing the intellectual property rights of intelligent connected vehicles2025-05-07On July 24, it’s reported by CCTV News today that at the 2023 China Automobile Innovation Conference held on July 23, China Automobile Technology and Research Center Co., Ltd. and Peking University jointly released the "Blue Paper on Automotive Standard Essential Patents", which is China’s first sys
- 
							【GE CHENG News】Ameile Patent from Hansoh Pharma wins China Patent Gold Award2025-05-07Recently, CNIPA issued its Decision on the Awarding of the 24th China Patent Award. The invention patent "EGFR Inhibitor and Preparation and Application Thereof" (Patent No.: ZL 201580045311.2) for the innovative drug Ameile (Aumolertinib Mesylate Tablets) developed by Hansoh Pharma, won the 24th Ch
- 
							【GE CHENG News】Livzon Group signs an agreement for patent and technology transfer with Synergy Pharmaceutical Sciences2025-05-07Livzon Group announced that it signed the "Patent and Technology Transfer Agreement" with Shanghai Synergy Pharmaceutical Sciences Co., Ltd. on July 19, 2023. According to the agreement, Synergy Pharmaceutical Sciences agreed to transfer and transfer all the rights, ownership, and interests of the H
- 
							【GE CHENG News】The State Council Information Office holds a press conference on intellectual property work in the first half of 20232025-05-07At the press conference, Hu Wenhui, deputy director of CNIPA, gave a brief introduction to the relevant situation of intellectual property work in the first half of 2023.1. Main DataFor patents: in the first half of the year, a total of 433,000 invention patents, 1.104 million utility model patents,
- 
							【GE CHENG News】DIAN Diagnostics claims that it has a series of auxiliary diagnostic software systems with independent intellectual property rights2025-05-07DIAN Diagnostics stated on the investor interaction platform on July 17 that it has a series of auxiliary diagnostic software systems with independent intellectual property rights. The company also claimed that it not only explores AI technology’s application in medical tests (such as report interpr
 
			